Pharmafile Logo
Pharmafocus logo
Advanced Search
Deepak Khanna image

PPRS to remain in UK, but drug growth curbed

November 6, 2013
Sales and Marketing ABPI, DH, Deepak Khanna, NHS, PPRS

The UK government has announced that the PPRS pricing scheme will largely remain intact, but will have a curb put …

News
Adheris image

inVentiv Health acquires Catalina Health

November 6, 2013
Medical Communications Adheris, catalina, inVentiv Health

Consulting and services company inVentiv Health has acquired a subsidiary of Catalina (Catalina Health) and joined it onto its own …

News
Roche image

ImmunoGen stops cancer trial

November 6, 2013
Research and Development, Sales and Marketing Cancer, IMGN901, Immunogen, Roche

Roche subsidiary ImmunoGen has abandoned a Phase II trial into small-cell lung cancer (SCLC) after deciding that it was not …

News
dan_bradbury

Profil Institute hires former Amylin chief executive

November 6, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amylin, profil institute

Clinical research firm Profil Institute has appointed former Amylin chief executive Dan Bradbury to its Board of directors.  “Dan Bradbury …

Appointment
ABPI reception

VBP diluted, NHS drugs bill to be reduced

November 5, 2013
Medical Communications, Research and Development, Sales and Marketing Horsham, PPRS, VBP

News
novartis_st_johann_night

Nearly 400 jobs to go at UK Novartis site

November 5, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, Sandwich

News
BIA image

UK is the go-to place for developing medicines

November 5, 2013
Research and Development, Sales and Marketing BIA, Cell Medica, ReNeuron, UK

The BioIndustry Association (BIA) has said that the UK is clearly the must-go-to location for regenerative medicine research and development. …

News
J&J image

J&J hit with $2.2 billion fine

November 5, 2013
Sales and Marketing J&J, JJ, Janssen, Risperdal, antipsychotic, fine

Johnson & Johnson has admitted promoting its big-selling antipsychotic drug Risperdal off-label, costing the firm $2.2 billion in fines. The …

News
BMS image

BMS files oral hep C treatment

November 5, 2013
Sales and Marketing BMS, HCV, dvc, hep C

Bristol-Myers Squibb has filed its investigational hepatitis C treatment – the first oral regime without interferon or ribavirin – with …

News
jeff_winton_astellas

Astellas poaches comms head from Lilly

November 5, 2013

Astellas has hired Jeffrey Winton from Eli Lilly to be its senior vice president and chief communications officer.Winton who will …

Appointment
GSK image

GSK ‘may not face corporate charges’

November 5, 2013
Medical Communications, Sales and Marketing China, GSK, bribery

GlaxoSmithKline is unlikely to face a company-wide charge for corruption following investigations by authorities in China according to reports. The …

News
roche image

Roche strikes $550 million antibiotics deal

November 4, 2013
Research and Development, Sales and Marketing Antibiotics, Roche, WHO

News
GSK logo

GSK: no Votrient Code breaches

November 4, 2013
Medical Communications, Sales and Marketing GSK, PMCPA, Pfizer

News
avril_lee_ketchum

Former Ketchum chief executive joins Luther Pendragon

November 4, 2013
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ketchum, Luther Pendragon

Appointment
WuXi AppTec's facility

WuXi AppTec hits big time in disposable manufacturing

November 4, 2013
Manufacturing and Production China, WuXi, antibody, bioreactors

News
manufacturing_pharma_1

Pharma facility news in brief

November 4, 2013
Manufacturing and Production DSM, GSK, manufacturing

News
FDA logo

FDA takes further action on drug shortages

November 4, 2013
Manufacturing and Production, Sales and Marketing FDA, Obama, US, drug shortages

News
Roche logo

FDA approves Roche’s new leukemia drug

November 4, 2013
Research and Development, Sales and Marketing Arzerra, CLL, FDA, GSK, Roche, chronic lymphocytic leukaemia

News
Obama image

Obamacare: health reform’s tough start

November 1, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medicare, Obama, Obamacare, US, affordable care act

On Tuesday 1 October, three years after it was passed, the Patient Protection and Affordable Care Act came into force …

Feature
Iclusig image

Ariad cancer drug pulled amid safety fears

November 1, 2013
Sales and Marketing Ariad, FDA, iclusig, leukaemia

Ariad Pharmaceuticals has been forced by the FDA to suspend sales of its blood cancer drug Iclusig given the high …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026